Clinical phase I peptide vaccination trial with a CMVpp65-derived peptide can prevent and clear CMVpp65 antigenemia after allogeneic hematopoietic stem cell transplantation
ONCOLOGY RESEARCH AND TREATMENT(2015)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要